Health Policy Affairs

The Executive Committee approved seven topics to be tackled by the Guidelines and Statements Division this year. They are:

• Update of the 2019 periprocedural management of thrombotic and bleeding patients
• Catheter-directed therapy for high-risk pulmonary embolism
• Thyroid radiofrequency ablation
• Percutaneous ablation of renal cell carcinoma
• Optimal therapy of popliteal/infrapopliteal artery disease in patients with critical limb ischemia
• Y-90 dosimetry and in combination with immunotherapy for hepatocellular carcinoma
• Bone and soft tissue ablation

The Guidelines and Statements Oversight Committee conducted an open call for topics in November 2024. These seven were selected after a review of literature and consideration of existing evidence, research in process, impact on patient care and clinical practice, and society priorities.